Ideal efficacy photoswitches for TRPC4/5 channels harness high potency for spatiotemporally-resolved control of TRPC function in live tissues
Markus Müller, Konstantin Niemeyer, Navin Kumar OjhaiD, Alin Sebastian PoraviD, Deivanayagabarathy VinayagamiD, Nicole D. UrbaniD, Fanny BüchauiD, Katharina Oleinikov, Mazen Makke, Claudia C. BaueriD, Aidan V. JohnsoniD, Stephen P. MuenchiD, Frank ZufalliD, Dieter BrunsiD, Yvonne N. Schwarz, Stefan RaunseriD, Trese Leinders‐ZufalliD, Robin S. BoniD, Michael SchaeferiD, Oliver Thorn‐SesholdiD
Abstract
Directly probing the endogenous biological roles of target proteins with high spatial and temporal resolution, as non-invasively and reproducibly as possible, is a shared conceptual goal for research across many fields, as well as for targeted therapies. Here we describe the rational conceptual design and test-case practical implementation of a photopharmacological paradigm to empower high-performance photomodulation studies in vivo. TRPC4/5 ion channels are involved in many spatiotemporally resolved circuits, from pain and anxiety, to reproductive signaling, digestion, and obesity. To unpick their biology requires spatiotemporally precise tools, which were lacking. We developed "ideal efficacy photoswitch" ligands to control their diverse functions in situ. These E{leftrightarrows}Z-photoswitchable ligands bias TRPC[4]/5 channel activity with exquisite photocontrol, from strong agonism under 360 nm, to low agonism at 385 nm, to strong antagonism at 410-460 nm. Cryo-EM structures of both TRPC4 and TRPC5 with both Z-agonists and E-antagonists support the rationale for efficacy switching through competitive E/Z isomer binding. Crucially, since the E/Z ratio is exclusively determined by the light wavelength applied, their channel photocontrol is exclusively wavelength-dependent, yet drug-concentration-independent: so is reproducible from cell culture to >millimetre-depth tissues. Indeed, we were able to photocontrol both direct and downstream TRPC4/5 biology in cell lines or primary cells in culture, from calcium flux, to primary neuron excitability and adrenaline release; and even in tissues, photoswitching small intestine motility and peristalsis. The TRPC4/5 ligands we develop will thus unlock a range of high-precision investigations in TRP biology. More broadly, we propose that the success of this efficacy photoswitch program, from concept to tissue level translation, is mainly a consequence of how biology has evolved proteins for efficacy control. We therefore foresee that a variety of functionally responsive protein targets, not only sensory and signaling ion channels and receptors, will be amenable to similarly high-performance photocontrol even in vivo, if a new generation of reagent development adopts this paradigm of ideal efficacy photoswitching. Table of Contents Graphic O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=84 SRC="FIGDIR/small/602451v1_ufig1.gif" ALT="Figure 1"> View larger version (24K): org.highwire.dtl.DTLVardef@1f8e527org.highwire.dtl.DTLVardef@18c72d0org.highwire.dtl.DTLVardef@1c5d648org.highwire.dtl.DTLVardef@177203d_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 13
- FWCI
- 26.72
- Field percentile
- top 1%
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cryo-EM structures of human TRPC5 reveal interaction of a xanthine-based TRPC1/4/5 inhibitor with a conserved lipid binding site.
David J. Wright, Katie J. Simmons, … Robin S. Bon·Communications BiologyPeer-reviewed·Nov 23, 2020
- Phototriggered proton-selective carrier currents through photoswitchable membranes
Juergen Pfeffermann, Rohit Yadav, … Peter Pohl·NanoscalePeer-reviewed·Dec 4, 2025
- Intracellular photoswitchable neuropharmacology driven by luminescence from upconverting nanoparticles.
Jun Wei Zhao, Graham C. R. Ellis‐Davies·Chemical CommunicationsPeer-reviewed·Jan 1, 2020
- Design, synthesis and pharmacological characterization of the first photoswitchable small-molecule agonist for the Atypical Chemokine Receptor 3
Sophie Bérenger, Justyna M. Adamska, … Rob Leurs·ACS OmegaPeer-reviewed·Feb 18, 2025
- Optical control of cardiac rhythm by in vivo photoactivation of an ERG channel peptide inhibitor
J. Montnach, H. Millet, … M. De Waard·bioRxiv·Mar 23, 2023
- Identification of compounds producing non-visual photosensation via TrpA1 in zebrafish
D. Cheng, M. McCarroll, … D. KOKEL·bioRxiv·Jun 10, 2020